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The incidence of diabetes is increasing at an alarming rate all
over the world. As a consequence, the complications related
to diabetes, including those aﬀecting the eye (cataracts
and retinopathy), nerve, and kidneys, are also becoming
more prevalent. In the eye, diabetes aﬀects both lens and
retina resulting in devastating eﬀects on vision. Although
signiﬁcant advances have been made towards understanding
their pathophysiology using animal models of diabetes,
progress in the area of development of pharmacological
means for their prevention and treatment is still very
minimal, if any. The pathogenetic mechanisms underlying
both of these ocular complications of diabetes are considered
multifactorial. The major factors considered to be involved
in diabetic cataractogenesis are the hyperglycemia-induced
excessivegenerationoffreeradicalsandconsequentoxidative
stress as well as aberrations in tissue metabolism. Free
radicals have also been implicated in the pathogenesis of
diabetic retinopathy (DR). In addition, DR is considered to
be associated with aberrations in several other cellular sig-
naling pathways mediated via inﬂammatory intermediators,
pigment epithelium-derived factor, various kinases, and Rho
and Ras GTPases. Identiﬁcation of pathways/molecules that
can be targeted for modiﬁcation by appropriate compounds
is highly essential for the development of pharmacological
therapy for these highly prevalent blinding diseases. In this
special issue intended to present new research on diabetic
cataractsandretinopathy,wehaveinvitedpapersthataddress
these issues.
The ﬁrst four articles in this issue are focused on
cataract formation in diabetes. The ﬁrst one provides an
overview of the pathogenesis of diabetic cataracts, clinical
studiesinvestigatingtheassociationbetweendiabetesandthe
development of cataract, and current treatment of cataracts
in the diabetic population. The anticataractogenic potential
of aldose reductase inhibitors and antioxidants has also been
discussed. The article by Petrash et al. focuses on the role
of aldo-ketoreductases in the eye. The expression proﬁles
of the AKR1B1 and AKRB10 have been characterized in
various human ocular tissues and their implications in the
pathogenesis of diabetic cataract have been discussed. The
next article examines the role of glyoxalase I in the inhi-
bition of methylglyoxal advanced glycation end products-
AGEs formation in lenses of transgenic mice overexpressing
human glyoxalase I, and the fourth one reviews the patho-
physiological characteristics of ocular complications in the
Spontaneously Diabetic Torii rat such as the formation of
cataracts which can become hypermature. It also suggests
the suitability of this model for the study of DR. Subsequent
articles in this issue focus on the pathogenesis of DR and
examine possible targets for pharmacological intervention.
The article by Daniel Ng reviews the genetic aspects of
DR, and the next article identiﬁes genes associated with DR
amongMexicanAmericansfromStarrCountyinTexasusing
genome-wide association study. The seventh paper examines
the possibility of treatment with the angiotensin-converting
enzyme inhibitor, trandolapril, for regression of DR, and2 Journal of Ophthalmology
the 8th paper discusses the role of toxic AGEs receptor in the
pathogenesis of DR. This is followed by a review implicating
Rho/ROCK (Rho Kinase) pathway in DR and suggests the
possibility of this pathway being a target for therapeutic
intervention. The article by Wu et al. investigates the role of
extracellular signal-regulated kinase 5 (ERK5) mediated sig-
naling in modulating glucose-induced expression of VEGF.
TheﬁnalpaperinthisissuecomparesNADPHoxidaseversus
mitochondria-derived reactive oxygen species in glucose-
induced apoptosis of pericytes in early DR.
This special issue will therefore provide the readers an
insight into some of the latest research being pursued to
elucidate the mechanisms underlying DR and cataracts.
It also presents some interesting targets which could be
manipulated pharmacologically for potential clinical use.
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